71 related articles for article (PubMed ID: 3158282)
21. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Hartmann JT; Kanz L; Bokemeyer C
Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
[TBL] [Abstract][Full Text] [Related]
22. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
[TBL] [Abstract][Full Text] [Related]
23. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
[TBL] [Abstract][Full Text] [Related]
24. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
[TBL] [Abstract][Full Text] [Related]
25. [Phase II study of THP patients with gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hada Y; Hosoma S; Hatayama T; Ogawa Y; Iwamori S; Nagata N
Gan To Kagaku Ryoho; 1986 Feb; 13(2):362-7. PubMed ID: 3947111
[TBL] [Abstract][Full Text] [Related]
26. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
[TBL] [Abstract][Full Text] [Related]
28. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
Nakano Y; Ohota J; Fujita M; Taguchi T
Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
[TBL] [Abstract][Full Text] [Related]
29. A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
Ajani JA; Kelsen DP; Haller D; Hargraves K; Healey D
Cancer J; 2000; 6(2):78-81. PubMed ID: 11069223
[TBL] [Abstract][Full Text] [Related]
30. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Takeda S; Taguchi T; Ohta J; Kurihara M; Abe T; Ohtani T; Yonemura Y; Ohno T; Hirabayashi N; Nakano S
Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
[TBL] [Abstract][Full Text] [Related]
31. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
[TBL] [Abstract][Full Text] [Related]
32. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study of 5'-deoxy-5-fluorouridine between older cancer patients versus younger cancer patients].
Sumimura J; Morimoto Y; Miyazaki M; Ishikawa S; Nagai I
Gan To Kagaku Ryoho; 1999 Mar; 26(4):561-4. PubMed ID: 10097759
[No Abstract] [Full Text] [Related]
34. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
[TBL] [Abstract][Full Text] [Related]
35. [Adjuvant chemotherapy with inductive multi-drug combination and long-term oral maintenance therapies for gastric cancer (author's transl)].
Nakajima T; Kajitani T
Nihon Gan Chiryo Gakkai Shi; 1980 Oct; 15(6):980-8. PubMed ID: 7276678
[No Abstract] [Full Text] [Related]
36. [A case of gastric carcinoma treated effectively with 5'-DFUR].
Gotoh M; Takiuchi H; Hirata I; Iyama M; Inoue R; Itabashi T; Egashira Y; Inoue T; Kurisu Y; Tanaka M; Shimamoto C; Katsu K
Gan To Kagaku Ryoho; 1999 May; 26(6):837-9. PubMed ID: 10410155
[TBL] [Abstract][Full Text] [Related]
37. [Clinical trial of 5'-DFUR against various malignant tumors].
Okumura T
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
[TBL] [Abstract][Full Text] [Related]
38. [Clinical phase II study of K-18 in cancer of the digestive organs].
Urushizaki I; Mogi Y; Kohgo Y; Onodera Y; Niitsu Y; Koyama R; Itaya H; Nakazawa O; Saijo N; Matsuda M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):361-4. PubMed ID: 2449136
[No Abstract] [Full Text] [Related]
39. [A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective].
Koda T; Kurahori T; Iwao N; Sumi S; Sonoda T; Yanagimoto H; Miyaji J; Okahisa N
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2571-4. PubMed ID: 3039923
[TBL] [Abstract][Full Text] [Related]
40. [Survival and changes of clinical laboratory data in phase II study with 5'-DFUR].
Taguchi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1019-29. PubMed ID: 8687216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
